- Home
- BMR vs AEON Comparison
BMR vs AEON Comparison
Compare BMR & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMR | AEON |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Israel | United States |
| Employees | 20 | 8 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 25.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMR | AEON |
|---|---|---|
| Price | $1.82 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | ★ 95.7K | 79.2K |
| Earning Date | 02-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $0.46 |
| 52 Week High | $4.32 | $1.45 |
Technical Indicators
Market Signals| Indicator | BMR | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 45.08 |
| Support Level | $1.76 | $0.82 |
| Resistance Level | $1.94 | $1.12 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 28.54 | 50.85 |
Price Performance
Historical ComparisonAbout BMR Beamr Imaging Ltd.
Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.